Please use this identifier to cite or link to this item: https://ah.lib.nccu.edu.tw/handle/140.119/111258
DC FieldValueLanguage
dc.contributor心理系-
dc.creatorLin, Chih-Linen-US
dc.creator林志陵zh-tw
dc.creatorKao, Jia-Horngen_US
dc.date2017-
dc.date.accessioned2017-07-20T07:20:11Z-
dc.date.available2017-07-20T07:20:11Z-
dc.date.issued2017-07-20T07:20:11Z-
dc.identifier.urihttp://nccur.lib.nccu.edu.tw/handle/140.119/111258-
dc.description.abstractHepatitis B virus (HBV) infection is prevalent in Asia, Africa, Southern Europe, and Latin America, where the rate of chronic HBV infection in the general population ranges from 2 to 20% .-
dc.format.extent361623 bytes-
dc.format.mimetypeapplication/pdf-
dc.relationHepatology International, 11(1), 31-33-
dc.titleHepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menaceen-US
dc.typearticle-
dc.identifier.doi10.1007/s12072-016-9782-x-
dc.doi.urihttp://dx.doi.org/10.1007/s12072-016-9782-x-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextrestricted-
item.openairetypearticle-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
Appears in Collections:期刊論文
Files in This Item:
File Description SizeFormat
10.1007_s12072-016-9782-x.pdf353.15 kBAdobe PDF2View/Open
Show simple item record

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.